Pancreatic Cancer Research

ResearcherUniversity Hospital MagdeburgNo recent work listed

Peter Malfertheiner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8439-9036; OpenAlex author ID A5048446588. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2012: 3 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 7

  1. Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of… Co-author DOI 10.1016/j.ejca.2020.12.029↗
  2. Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional mul… Co-author DOI 10.1186/s12885-020-6636-7↗
  3. Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis. Co-author DOI 10.1155/2019/5832309↗
  4. Combined Systemic Chemotherapy and CT-Guided High-Dose-Rate Brachytherapy for Isolated Local Manifestation of Pancreatic Cancer after Surgical Resection. Co-author DOI 10.1159/000487359↗
  5. L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial. Co-author DOI 10.1186/1475-2891-11-52↗
  6. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. Last author DOI 10.1371/journal.pone.0042933↗
  7. [Helicobacter pylori infection in pancreatic cancer]. Co-author PMID 22590913↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Caspar Franck · 2 shared papers, 2018–2019 · strength 0.24
  2. Marino Venerito · 2 shared papers, 2018–2019 · strength 0.24
  3. Volker Heinemann · 2 shared papers, 2020–2021 · strength 0.20
  4. Dirk Waldschmidt · 2 shared papers, 2020–2021 · strength 0.20
  5. Christoph Benedikt Westphalen · 2 shared papers, 2020–2021 · strength 0.20
  6. Michael Haas · 1 shared paper, 2021 · strength 0.10
  7. Stephan Krüger · 1 shared paper, 2021 · strength 0.10
  8. Michael Ståhl · 1 shared paper, 2021 · strength 0.10
  9. Thomas Theodor Werner Seufferlein · 1 shared paper, 2021 · strength 0.10
  10. Anke Reinacher‐Schick · 1 shared paper, 2021 · strength 0.10
  11. Stefan Hubert Boeck · 1 shared paper, 2021 · strength 0.10
  12. Alicja Gawin · 1 shared paper, 2012 · strength 0.04
  13. Teresa Starzyñska · 1 shared paper, 2012 · strength 0.04
  14. Alexander Link · 1 shared paper, 2012 · strength 0.04
  15. Ajay Goel · 1 shared paper, 2012 · strength 0.04
  16. Jens Stieler · 1 shared paper, 2012 · strength 0.02
  17. Claudia J. Nitsche · 1 shared paper, 2012 · strength 0.02
  18. Simone Gärtner · 1 shared paper, 2012 · strength 0.02
  19. Péter Simon · 1 shared paper, 2012 · strength 0.02
  20. Matthias Kraft · 1 shared paper, 2012 · strength 0.02
  21. Ali Alexander Aghdassi · 1 shared paper, 2012 · strength 0.02
  22. Julia V. Mayerle · 1 shared paper, 2012 · strength 0.02
  23. Markus M. Lerch · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.